(SNSS) Community Analysis from
Bulls REASONS TO BUY
|
100%
agree
2 votes
|
Merger coming |
|
100%
agree
1 votes
|
Huge recent institutional buying |
Bears REASONS TO SELL
May 24, 2013
(Penny Stock DD,
2/9/11)
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) surged by 9.52% and closed at $0.46 whereas overall traded volume stood at 4.66 million shares for the day as compare to its...(read more)
(Penny Stock DD,
1/26/11)
BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) surged by 5.35% to close at $1.97 with overall traded volume of 8.79 million shares in the last trading day. The company...(read more)
(Benzinga,
10/20/10)
Adam Feuerstein, senior biotech writer at the TheStreet.com, tweeted that he thinks that Cell Therapeutics, Inc. (NASDAQ: CTIC) may buy Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS).
This is all speculation on his part, and there has...(read more)
Sunesis Pharmaceuticals (SNSS) Company Overview
There is no analysis for SNSS yet. But you can go to Wikinvest to help create one!
